July 2017 ENCALS statement on edaravoneCHU Tours, France.
CHU Limoges, France.
Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Medicine and Health Sciences.
University of Lisbon, Portugal; H Santa Maria CHLN, Portugal.
CHU Nice, France.
Alfried Krupp Hospital, Germany.
Jena University Hospital, Germany.
Kershus University of Lorenskog, Norway.
Karolinska Institute, Sweden.
Bispebjerg Hospital, Denmark.
Sykehuset Innlandet, Norway.
University of Medical Gottingen, Germany.
University of Medical Centre Ljubljana, Slovenia.
Medical University of Warsaw, Poland.
University of Helsinki, Finland.
University of Ulm, Germany.
University of Sheffield, England.
University of Medical Berlin, Germany.
Sahlgrens University Hospital, Sweden.
Hospital San Rafael, Spain.
Uppsala University, Sweden.
Hannover Medical Sch, Germany.
University of Bellvitge, Spain.
Hop Salptriere, France.
University of Sheffield, England.
University of Milan, Italy; University of Milan, Italy.
Lund University, Sweden.
Bispebjerg Hospital, Denmark.
University of Oxford, England.
Haukeland University of Sjukehus, Norway.
University of Leuven, Belgium; VIB Centre Brain and Disease Research, Belgium; University Hospital Leuven, Belgium.
University of Amsterdam Centre, Netherlands.
Kantonssp St Gallen, Switzerland.
University of Bonn, Germany.
Diakonissen Hospital, Germany.
Trinity Coll Dublin, Ireland.
University of Medical Centre Utrecht, Netherlands.
Show others and affiliations
2017 (English)In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ISSN 2167-8421, E-ISSN 2167-9223, Vol. 18, no 7-8, p. 471-474Article in journal (Refereed) Published
Abstract [en]
n/a
Place, publisher, year, edition, pages
TAYLOR & FRANCIS LTD , 2017. Vol. 18, no 7-8, p. 471-474
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-143377DOI: 10.1080/21678421.2017.1369125ISI: 000415817900001PubMedID: 28975816OAI: oai:DiVA.org:liu-143377DiVA, id: diva2:1162736
Note
Funding Agencies|Biogen Idec; Orphazyme ApS; Roche; Biogen; Merck Idec; Kedrion; Cytokinetics; Genzyme; Mitsubishi; Behring; Merz Parma Schweiz; Baxalta; Merck
2017-12-052017-12-052017-12-05